Florida Surgeon General Says Biden Is ‘Actively Preventing’ Monoclonal Shipments

Florida Surgeon General Dr. Joseph Ladapo sent a letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra saying the Biden Administration is “actively preventing” the shipments on Regeneron’s monoclonal antibody treatments to states, including Florida.

Read More

Feds Trim Florida’s Monoclonal Antibody Allotment After State Fueled National Surge in Demand

Florida Gov. Ron DeSantis has spent two months cross-crossing the state promoting sites and clinics that offer monoclonal antibody treatments, an increasingly popular alternative to vaccines for protection from COVID-19.

In fact, so popular that last week, the U.S. Department of Health & Human Services (DHS), while increasing overall supplies by 50%, from 100,000 to 150,000 doses a week nationwide, but capping the number of doses being delivered to Florida and six other Southern states that had previously consumed more than 70% of the nation’s monoclonal antibody treatments.

Read More

Two Big Pharmaceutical Companies Sell Monoclonal Antibodies to Federal Government Only, Refuse to Sell to Hospitals or States

Officials with two pharmaceutical companies who produce monoclonal antibody treatments said Wednesday that the U.S. government distributes the currently-available supply of those treatments and that those companies may not sell them to hospitals or state governments. A spokesman for the New York state-based Regeneron, who identified himself only as Alex, said the U.S. government owns the currently available supply of REGEN-COV, which is the company’s monoclonal antibody treatment. The U.S. government allocates that product to state governments.

Read More

Demand Soaring in Michigan for ‘Antibody Cocktail’ in Fight Against Coronavirus

Demand is soaring for an “antibody cocktail” that can greatly diminish the severity of coronavirus cases, Michigan Radio reported.

The antibody cocktail created by Regeneron is the same former President Donald Trump received after he contracted the virus and is intended to be administered only after a patient has contracted the disease.

Read More

Regeneron Proves Effective; Where to Get Treatment at Tennessee Medical Facilities

As confirmed cases of the coronavirus continue to rise throughout the country, monoclonal antibody treatments, such as Regeneron, are becoming a widespread source of treatment.

Across the state of Tennessee, hundreds of locations are providing the treatment to individuals who have tested positive for the virus.

Read More

Governor DeSantis Supports Monoclonal Antibody Treatment for High-Risk COVID Patients

Governor DeSantis expressed his support for Regeneron’s monoclonal antibody treatment Thursday, as COVID cases and the number of hospitalizations continue to surge in Florida.

According to DeSantis, “These treatments have been proven successful, with clinical trials resulting in a 70% reduction in hospitalization and death for COVID patients,” especially those who have higher risk for severe complications due to age or preexisting medical conditions.

As reported by the Food and Drug Administration (FDA), “Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses.” The treatment is meant for individuals who have tested positive or recovered from COVID.

Read More